Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Do elevated basophil and eosinophil percentages suggest a Th2 allergic or mucosal immune response?

Concurrent basophil and eosinophil percentage elevations are a classic sign of a type 2 immune response and are more suggestive of allergic, histamine-related, or parasitic causes than acute infection.

PlausibleJuly 20, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Basophil and eosinophil percentage elevations can reflect allergic, histamine-related Th2 or mucosal immune skew rather than acute infection.

laying out figure…
2 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that when basophil and eosinophil percentages rise together, the pattern points toward a Th2-polarized mucosal immune response. The mechanism frames this as being driven by IL-4, IL-5, and IL-13 signaling, with basophils supporting IgE and histamine pathways and eosinophils tracking type 2 immune activity. It also notes that this pattern is not typical of acute bacterial or viral infection, which usually follows different leukocyte shifts.

Verified conclusion

Concurrent elevations of peripheral basophil and eosinophil percentages serve as a classic laboratory signature of a type 2 (Th2) polarized immune response rather than an acute infectious process.

Mechanistic drivers of type 2 immunity

  • Cytokine signaling: This coordinated leukocyte expansion is driven by epithelial "alarmins" and Th2-derived cytokines, specifically interleukin-4 (IL-4), IL-5, and IL-13.
  • Cellular feedback loops: IL-5 drives bone marrow differentiation, survival, and mucosal homing of eosinophils. Concurrently, basophils act as early sources of IL-4, establishing a positive feedback loop that promotes B-cell class switching to IgE and fuels histamine-mediated allergic pathways.
  • Clinical associations: This dual elevation is highly characteristic of mucosal allergic diseases (such as allergic rhinitis, asthma, and chronic urticaria) as well as helminth (parasitic) infections, which rely on the same protective Th2 mucosal barrier toolkit.

Divergence from acute infectious responses

  • Alternative immune pathways: Acute bacterial and viral infections predominantly activate Th1 or Th17 pathways. These immune responses manifest hematologically as neutrophilia, monocytosis, or lymphocytosis.
  • Diagnostic differentiation: Because acute infectious processes do not classically present with eosinophilic or basophilic shifts, concurrent elevations in these granulocytes effectively steer the differential diagnosis away from acute infection and toward a Th2-mediated allergic or parasitic etiology.

Bottom line

  • Concurrent elevations in basophil and eosinophil percentages indicate a polarized Th2 mucosal immune response—driven by IL-4 and IL-5 pathways—which is highly suggestive of allergic, histamine-mediated, or parasitic processes rather than an acute bacterial or viral infection.

References

  1. How are TH2-type immune responses initiated and amplified? - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. Pathobiology and Regulation of Eosinophils, Mast Cells, and ... — pmc.ncbi.nlm.nih.gov ↗
  3. Effector mechanisms in allergic reactions - Immunobiology - NCBIwww.ncbi.nlm.nih.gov › books › NBK27112 — ncbi.nlm.nih.gov ↗
  4. Basophil Test - Biomarker - Loovi — loovi.health ↗
  5. Eosinophilia - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Eosinophilia - Wikipedia — en.wikipedia.org ↗
  7. Eosinophils in mucosal immune responses - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  8. INFECTION AND IMMUNITY, Dec. 1995, p. 4653–4660 — pmc.ncbi.nlm.nih.gov ↗
  9. Barrier Epithelial Cells and the Control of Type 2 Immunity — cell.com ↗
  10. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. — academic.oup.com ↗
  11. Immunologic mechanisms in asthma. — linkinghub.elsevier.com ↗
  12. Basophils and allergic inflammation - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  13. NIH Public Access — thebloodproject.com ↗
  14. Eosinophils in mucosal immune responses - Mucosal Immunology — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→